| Financial Year |
March 31 2023 |
| Monetary Funds |
704,058,019.17 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
750,000.00 |
| Accounts Receivable |
22,802,517.40 |
| Advances to Suppliers |
23,861,638.91 |
| Other Receivables |
20,135,588.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,643,876,273.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
939,748,329.52 |
| Total Current Assets |
3,355,232,366.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,093,526.74 |
| Investment Properties |
509,786,461.05 |
| Fixed Assetes |
1,579,400,067.88 |
| Under-construction Projects |
407,840,820.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
186,920,857.12 |
| R&D expenses |
-- |
| Goodwill |
1,500,000.00 |
| Long-Term Deferred and Prepaid Expenses |
27,986,513.43 |
| Deferred Income Tax Assets |
84,311,470.92 |
| Other Non-Current Assets |
27,295,669.10 |
| Sub-Total of Non-Current Assets |
2,862,836,080.44 |
| Total Assets |
6,218,068,447.08 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
200,000,000.00 |
| Accounts Payable |
459,711,695.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
76,098,977.20 |
| Taxes Payable |
64,937,423.75 |
| Interest Payable |
-- |
| Dividend Payable |
44,474,839.82 |
| Other payables |
350,769,020.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,667,860.06 |
| Other Current Liabilities |
11,438,241.45 |
| Sub-Total of Current Liabilities |
1,263,115,413.87 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,178,358,704.12 |
| Deferred Income Tax Liabilities |
86,956,184.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,330,732,540.64 |
| Total Liabilities |
2,593,847,954.51 |
| Paid-In Capital(Or Share Stock) |
785,375,950.00 |
| Capital Surplus |
3,225,772.96 |
| Surplus Reserve |
100,428,084.41 |
| LESS:Treasury Stock |
599,895,430.21 |
| Undistributed Profits |
2,852,979,588.24 |
| Minority Stockholder's Interest |
465,509,744.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,158,710,748.50 |
| Owner's Equity（Stockholder's Equity） |
3,624,220,492.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,218,068,447.08 |
